nucleos(t)ide - Globe Thesis

Keyword [nucleos(t)ide] Result: 21 - 40 \| Page: 2 of 5
21.	Study On Relationship Between HBV Relapse And Serum Low-load HBV DNA In CHB Patients Meeting NAs Cessation Criteria
22.	Clinical Features Of Chronic Hepatitis B Relapse After Nucleos(T)Ide Analogues Withdrawal
23.	The Predictive Value Of Baseline Characteristics On Efficacy Of Nucleos(t)ide Analogues In Patients With Chronic Hepatitis B
24.	The Occurance Of HbsAg Clearance Or Seroconvertion Pegylated Interferon Based Therapy In The Treatment Of Chronic Hepatitis B: A Meta-analysis Of Clinical Controlled Trials
25.	Study Of Predictors Of Virological Breakthrough To Chronic Hepatitis B Treated In Nucleos(t)ide Analogues
26.	Study On Off-treatment Efficacy Durability Of Nucleos(t)ide Analogues And Influencing Factors In Chronic Hepatitis B Patients
27.	The Features Of Peripheral Blood Mononuclear Cell Secreting Interferon-alfa In Patients With Chronic Hepatitis B Virus Infection&Long-term Outcomes Of Nucleos(t)ide Therapy In Patients With Chronic Hepatitis B
28.	Mutation Analysis Of The HBV Reverse Transcriptase In Nucleos(t)Ide-treatedpatients With Chronic HBV Infection
29.	The Effects Of NAs Antiviral Therapy For Patients With Severe Acute Exacerbation And Patients Relapsed After NAs Withdrawal
30.	The Correlation Of Nucleos(T)IDE Analogues Adherence With The Occurrence Of Drug-resistant In Patients With Chronic Hepatitis B
31.	Treatment With Nucleos(t)ide Analogue And Thymosin Alpha-1Versus Nucleos(t)ide Analogue Monotherapy For HBeAg-positive Chronic Hepatitis B: A Meta-analysis
32.	Meta-analysis:Long-term Nucleos(t)ide Analogues Therapy For Decompensated Cirrhosis Due To Hepatitis B
33.	Study Of Nucleos(t)ide Analogues Resistant In Treatment Of Chronic Hepatitis B And Primary Liver Cancer Clinical Characteristics
34.	The Change Of Serum HBsAg And HBeAg Levels In Chronic Hepatitis B Patients During Antiviral Therapy And Their Role In Predicting Response
35.	Impact Of Nucleos(t)Ide Analogues On The Estimated Glomerular Filtration Rate In Patients With Chronic Hepatitis B
36.	Analysis Of HBV Drug-resistant Mutations In 147 Virologic Breakthrough Patients With Chronic Hepatitis B
37.	Comparison Of The Antiviral Effects Of Different Nucleos(t)ide Analogues In Chinese Patients With Chronic Hepatitis B: A Head-to-Head Study
38.	The Kinetics Of HBsAg During Long Term Nucleos(t)Ide Analogue Treatment In Chronic Hepatitis B Patients
39.	The Expression And Clinical Significance Of Interleukin-21 After Discontinuation Of Nucleos(t)ide Analogue Therapy In Patients With Chronic Hepatitis B
40.	Molecular Epidemiology Study Of The Genotypic Mutations Conferring Resistance To Nucleos(t)ide Analogues From Clinical Specimens Of Patients With Hepatitis B
<<First <Prev Next> Last>> Jump to